enVVeno Medical NVNO
NASDAQ NVNO
$6.17 -0.40 (-6.09%)
At close: Nov 13, 2026 · 4:00 PM EST

enVVeno Medical (NVNO) Gains (Losses) on Sale of Assets & Investments (2022 - 2026)

Updated

enVVeno Medical's Gains (Losses) on Sale of Assets & Investments came in at $174,000 for Q3 2026, down 16.3% from $208,000 a year earlier and down 16.7% from the prior quarter.

Analysis

enVVeno Medical (NVNO) Gains (Losses) on Sale of Assets & Investments (2022 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, enVVeno Medical reported Gains (Losses) on Sale of Assets & Investments of $874,000, down 32.7% year-over-year; for FY2025, it was $1.13 million, down 31.3% from FY2024.

  • Gains (Losses) on Sale of Assets & Investments carries a three-year compound annual growth rate of 177.0% (FY2022 to FY2025).
  • Going back by year, Gains (Losses) on Sale of Assets & Investments was $1.64 million in FY2024 (+52.7%), $1.07 million in FY2023 and $53,000 in FY2022.
  • The Q3 2026 figure represents the lowest quarterly Gains (Losses) on Sale of Assets & Investments since Q3 2023.
  • Year-over-year, Gains (Losses) on Sale of Assets & Investments has declined for six consecutive quarters, with an average decline of 29.3% over the last eight quarters.
  • The fastest year-over-year change in Gains (Losses) on Sale of Assets & Investments over five years came in Q1 2024 (growth of 397.6%), and the weakest in Q3 2025 (a decline of 51.4%).
  • Business Quant data shows NVNO's Gains (Losses) on Sale of Assets & Investments at $209,000 (Q2 2026), $238,000 (Q1 2026) and $253,000 (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn -
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn -
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn -
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn -
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn -
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn -
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn -
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn -
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn 13.00 Mn
10 enVVeno Medical 4.29 Mn -88.81 Mn - 174,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 174,000.00
Jun 30, 2026 209,000.00
Mar 31, 2026 238,000.00
Dec 31, 2025 253,000.00
Sep 30, 2025 208,000.00
Jun 30, 2025 239,000.00
Mar 31, 2025 426,000.00
Dec 31, 2024 425,000.00
Sep 30, 2024 428,000.00
Jun 30, 2024 379,000.00
Mar 31, 2024 408,000.00
Dec 31, 2023 676,000.00
Sep 30, 2023 148,000.00
Jun 30, 2023 168,000.00
Mar 31, 2023 82,000.00
Dec 31, 2022 187,000.00
Sep 30, 2022 -21,000.00
Jun 30, 2022 -113,000.00
API Access

enVVeno Medical Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=NVNO&period=max&api_key=YOUR_API_KEY